Close

Cantor Fitzgerald Starts Evoke Pharma (EVOK) at Buy

November 4, 2013 7:33 AM EST Send to a Friend
Cantor Fitzgerald initiates coverage on Evoke Pharma (NASDAQ: EVOK) with a Buy. PT $19.00.

Analyst Irina Rivkind comments, "Evoke ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login